Status: current, Defined. Date: 31-Dec 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3850461000168117 | Evotaz (atazanavir 300 mg + cobicistat 150 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3850471000168111 | Evotaz tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Evotaz tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Evotaz tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Evotaz tablet | Is a | Evotaz | true | Inferred relationship | Some | ||
| Evotaz tablet | Is a | atazanavir 300 mg + cobicistat 150 mg tablet | true | Inferred relationship | Some | ||
| Evotaz tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Evotaz tablet | has unit of use | tablet | true | Inferred relationship | Some | 921264515 | |
| Evotaz tablet | has Australian BoSS | cobicistat | true | Inferred relationship | Some | 471464078 | |
| Evotaz tablet | has intended active ingredient | cobicistat | true | Inferred relationship | Some | 471464078 | |
| Evotaz tablet | has Australian BoSS | atazanavir | true | Inferred relationship | Some | 921264514 | |
| Evotaz tablet | has intended active ingredient | atazanavir | true | Inferred relationship | Some | 921264514 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Evotaz tablet, 30 | has TPUU | True | Evotaz tablet | Inferred relationship | Some | 1 |
| Evotaz tablet, 30, bottle | has TPUU | True | Evotaz tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR